iRhythm Technologies, Inc. (NASDAQ:IRTC) management will conduct a conference call for 5th November 2020 at 4:30 PM Eastern Time to discuss financial results and companys performance for 3Q20.
The conference call will also be available live on the website www.iRhythmTech.com
Earnings Expectation
iRhythm Technologies, Inc. is reporting third quarter financial results on Thursday 5th November 2020, after market close.
According to analysts surveyed by Thomson Reuters, IRTC is expected to report 3Q20 loss of $ 0.51 per share from revenue of $ 62.33 million.
For the full year, analysts anticipate top line of $ 250.98 million, while looking forward to loss of $ 1.98 per share bottom line.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 280.00 million ~ $ 290.00 million
Click Here For More Historical Outlooks Of iRhythm Technologies, Inc.
iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. The company offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. Its Zio XT monitor, a single-use, wire-free, and wearable patch-based biosensor, records patients heartbeats and ECG data.
